A randomized trial of ribavirin and interferon-α vs. interferon-α alone in patients with chronic hepatitis C who were non-responders to a previous treatment
- 31 July 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (1), 1-7
- https://doi.org/10.1016/s0168-8278(99)80157-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- EFFECTS OF THE RIBAVIRIN-INTERFERON α COMBINATION ON CULTURED PERIPHERAL BLOOD MONONUCLEAR CELLS FROM CHRONIC HEPATITIS C PATIENTSCytokine, 1998
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C: Meta-analysis of individual patient data from European centersJournal of Hepatology, 1997
- Combined treatment with interferon alpha‐2b and ribavirin for chronic hepatitis C in patients with a previous non‐response or non‐sustained response to interferon aloneJournal of Medical Virology, 1995
- Factors predictive of response to interferon-α therapy in hepatitis C virus infectionHepatology, 1994
- Ribavirin in the treatment of chronic hepatitis C unresponsive to alfa interferonJournal of Hepatology, 1993
- Hepatitis C viral RNA titers in serum prior to, during, and after oral treatment with ribavirin for chronic hepatitis CJournal of Medical Virology, 1993
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981